My NCBISign In
Dermatological conditions during TNF-α-blocking therapy in patients with rheumatoid arthritis: a prospective study
Marcel Flendrie, Wynand HPM Vissers, Marjonne CW Creemers, Elke MGJ de Jong, Peter CM van de Kerkhof, Piet LCM van Riel
Arthritis Res Ther. 2005; 7(3): R666–R676. Published online 2005 April 4. doi: 10.1186/ar1724
PMCID:
PMC1174960
Abstract Full Text PDF–354K

Is Cited by the Following 12 Articles in this Archive:

Vitiligo during Treatment of Crohn's Disease with Adalimumab: Adverse Effect or Co-Occurrence?
Celia Posada, Ángeles Flórez, Ana Batalla, Juan José Alcázar, Daniel Carpio
Case Rep Dermatol. 2011 Jan-Apr; 3(1): 28–31. Published online 2011 February 5. doi: 10.1159/000324619
PMCID:
PMC3175360
Abstract Full Text PDF–135K
Safety of treatment with biologics for psoriasis in daily practice: 5-year data
PPM Van Lümig, RJB Driessen, MAM Berends, J B Boezeman, PCM van de Kerkhof, EMGJ de Jong
J Transl Med. 2010; 8(Suppl 1): P16. Published online 2010 November 25. doi: 10.1186/1479-5876-8-S1-P16
PMCID:
PMC3007758
Full Text PDF–125K
Tumor necrosis factor-inhibitor associated dermatomyositis
RS Klein, M Rosenbach, EJ Kim, B Kim, VP Werth, J Dunham
Arch Dermatol. Author manuscript; available in PMC 2011 July 1.
Published in final edited form as: Arch Dermatol. 2010 July; 146(7): 780–784. doi: 10.1001/archdermatol.2010.142
PMCID:
PMC2909024
Abstract Full Text PDF–1.5M
Long-term use of adalimumab in the treatment of moderate to severe plaque psoriasis: a review of the literature
Angela Y Moore, Blakely S Richardson
Clin Cosmet Investig Dermatol. 2010; 3: 49–58. Published online 2010 April 19.
PMCID:
PMC3047941
Abstract Full Text PDF–163K
Masitinib in the treatment of active rheumatoid arthritis: results of a multicentre, open-label, dose-ranging, phase 2a study
Jacques Tebib, Xavier Mariette, Pierre Bourgeois, René-Marc Flipo, Philippe Gaudin, Xavier Le Loët, Paul Gineste, Laurent Guy, Colin D Mansfield, Alain Moussy, Patrice Dubreuil, Olivier Hermine, Jean Sibilia
Arthritis Res Ther. 2009; 11(3): R95. Published online 2009 June 23. doi: 10.1186/ar2740
PMCID:
PMC2714151
Abstract Full Text PDF–153K
Repeated Paradoxical Aggravation of Preexisting Psoriasis during Infliximab Treatment for Crohn's Disease
Byung Cheol Park, Hyun Jung Lim, Byung Soo Kim, Weon Ju Lee, Do Won Kim, Seok-Jong Lee
Ann Dermatol. 2009 February; 21(1): 60–62. Published online 2009 February 28. doi: 10.5021/ad.2009.21.1.60
PMCID:
PMC2883373
Abstract Full Text PDF–720K
Adalimumab in dermatology
Pawel Traczewski, Lidia Rudnicka
Br J Clin Pharmacol. 2008 November; 66(5): 618–625. Published online 2008 August 28. doi: 10.1111/j.1365-2125.2008.03263.x
PMCID:
PMC2661976
Abstract Full Text PDF–590K
Rates of new-onset psoriasis in patients with rheumatoid arthritis receiving anti-tumour necrosis factor α therapy: results from the British Society for Rheumatology Biologics Register
M J Harrison, W G Dixon, K D Watson, Y King, R Groves, K L Hyrich, D P M Symmons, and the British Society for Rheumatology Biologics Register Control Centre Consortium
Ann Rheum Dis. 2009 February; 68(2): 209–215. Published online 2008 April 2. doi: 10.1136/ard.2007.087288
PMCID:
PMC2605571
Abstract Full Text PDF–186K
Manifestation of palmoplantar pustulosis during or after infliximab therapy for plaque-type psoriasis: report on five cases
Rotraut Mössner, Diamant Thaci, Johannes Mohr, Sylvie Pätzold, Hans Peter Bertsch, Ullrich Krüger, Kristian Reich
Arch Dermatol Res. 2008 March; 300(3): 101–105. Published online 2008 February 1. doi: 10.1007/s00403-008-0831-8
PMCID:
PMC2254657
Abstract Full Text PDF–355K
Psoriasis after treatment of juvenile idiopathic arthritis with etanercept
R Peek, R Scott‐Jupp, H Strike, J Clinch, A V Ramanan
Ann Rheum Dis. 2006 September; 65(9): 1259. doi: 10.1136/ard.2005.049916
PMCID:
PMC1798298
Full Text PDF–144K
Cutaneous abnormalities in rheumatoid arthritis compared with non‐inflammatory rheumatic conditions
K M J Douglas, E Ladoyanni, G J Treharne, E D Hale, N Erb, G D Kitas
Ann Rheum Dis. 2006 October; 65(10): 1341–1345. Published online 2006 February 13. doi: 10.1136/ard.2005.048934
PMCID:
PMC1798318
Abstract Full Text PDF–139K
New onset or exacerbation of psoriatic skin lesions in patients with definite rheumatoid arthritis receiving tumour necrosis factor α antagonists
S Kary, M Worm, H Audring, D Huscher, M Renelt, H Sörensen, E Ständer, U Maaß, H Lee, W Sterry, G‐R Burmester
Ann Rheum Dis. 2006 March; 65(3): 405–407. Published online 2005 September 8. doi: 10.1136/ard.2005.037424
PMCID:
PMC1798046
Abstract Full Text PDF–562K
You are here: NCBI > Literature > PubMed Central (PMC)
Write to the Help Desk